Extract from the Register of European Patents

EP About this file: EP3146065

EP3146065 - METHODS AND COMPOSITIONS FOR REDUCING CLOSTRIDIUM DIFFICILE INFECTION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.09.2025
Database last updated on 01.04.2026
FormerThe patent has been granted
Status updated on  11.10.2024
FormerGrant of patent is intended
Status updated on  09.06.2024
FormerExamination is in progress
Status updated on  07.02.2019
FormerRequest for examination was made
Status updated on  24.02.2017
FormerThe international publication has been made
Status updated on  16.12.2016
Most recent event   Tooltip06.02.2026Lapse of the patent in a contracting state
New state(s): MC
published on 11.03.2026  [2026/11]
Applicant(s)For all designated states
Memorial Sloan Kettering Cancer Center
1275 York Avenue
New York, NY 10065 / US
[2017/13]
Inventor(s)01 / PAMER, Eric, G.
84 Fair Street
Guilford, CT 06437-26117 / US
02 / BUFFIE, Charlie
1230 York Avenue
Box 14
New York, NY 10065 / US
03 / MCKENNEY, Peter
504 E8 1st St Apt 1E
New York, NY 10028 / US
 [2017/18]
Former [2017/13]01 / PAMER, Eric, G.
84 Fair Street
Guilford, CT 06437-26117 / US
02 / BUFFIE, Charlie
1230 York Avenue
Box 14
New York, NY 10065 / US
03 / MCKENNEY, Peter
75 West Street
Apt. 5E
New York, NY 10006 / US
Representative(s)Barker Brettell LLP
100 Hagley Road
Edgbaston
Birmingham B16 8QQ / GB
[2024/46]
Former [2017/13]Atkinson, Jennifer
Barker Brettell LLP
100 Hagley Road
Edgbaston
Birmingham B16 8QQ / GB
Application number, filing date15796000.619.05.2015
[2017/13]
WO2015US31627
Priority number, dateUS201462000308P19.05.2014         Original published format: US 201462000308 P
[2017/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015179437
Date:26.11.2015
Language:EN
[2015/47]
Type: A1 Application with search report 
No.:EP3146065
Date:29.03.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 26.11.2015 takes the place of the publication of the European patent application.
[2017/13]
Type: B1 Patent specification 
No.:EP3146065
Date:13.11.2024
Language:EN
[2024/46]
Search report(s)International search report - published on:US26.11.2015
(Supplementary) European search report - dispatched on:EP13.04.2018
ClassificationIPC:C12Q1/26, A61K35/74
[2017/13]
CPC:
A61K35/74 (EP,US); A61K31/545 (EP); A61K35/741 (EP);
A61K35/742 (EP); A61K38/443 (EP,US); A61K45/06 (EP,US);
A61P31/00 (EP); C12N9/0006 (EP,US); C12Q1/26 (EP,US);
C12Y101/01159 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/13]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNGEN ZUR VERRINGERUNG VON CLOSTRIDIUM-DIFFICILE-INFEKTIONEN[2017/13]
English:METHODS AND COMPOSITIONS FOR REDUCING CLOSTRIDIUM DIFFICILE INFECTION[2017/13]
French:PROCÉDÉS ET COMPOSITIONS POUR RÉDUIRE UNE INFECTION PAR CLOSTRIDIUM DIFFICILE[2017/13]
Entry into regional phase16.12.2016National basic fee paid 
16.12.2016Search fee paid 
16.12.2016Designation fee(s) paid 
16.12.2016Examination fee paid 
Examination procedure16.12.2016Examination requested  [2017/13]
16.12.2016Date on which the examining division has become responsible
13.11.2018Amendment by applicant (claims and/or description)
11.02.2019Despatch of a communication from the examining division (Time limit: M06)
21.08.2019Reply to a communication from the examining division
26.02.2020Despatch of a communication from the examining division (Time limit: M06)
10.09.2020Reply to a communication from the examining division
26.02.2021Despatch of a communication from the examining division (Time limit: M04)
08.07.2021Reply to a communication from the examining division
10.06.2024Communication of intention to grant the patent
03.10.2024Fee for grant paid
03.10.2024Fee for publishing/printing paid
03.10.2024Receipt of the translation of the claim(s)
Divisional application(s)EP24212532.6  / EP4527400
EP25222653.5  / EP4684833
Opposition(s)14.08.2025No opposition filed within time limit [2025/43]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
10.09.2020Request for further processing filed
10.09.2020Full payment received (date of receipt of payment)
Request granted
21.09.2020Decision despatched
Fees paidRenewal fee
10.05.2017Renewal fee patent year 03
11.05.2018Renewal fee patent year 04
15.05.2019Renewal fee patent year 05
31.03.2020Renewal fee patent year 06
12.05.2021Renewal fee patent year 07
18.03.2022Renewal fee patent year 08
14.03.2023Renewal fee patent year 09
13.03.2024Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBG13.11.2024
CZ13.11.2024
EE13.11.2024
HR13.11.2024
LV13.11.2024
MC13.11.2024
PL13.11.2024
RO13.11.2024
SK13.11.2024
SM13.11.2024
RS13.02.2025
GR14.02.2025
IS13.03.2025
LU19.05.2025
[2026/11]
Former [2026/08]BG13.11.2024
CZ13.11.2024
EE13.11.2024
HR13.11.2024
LV13.11.2024
PL13.11.2024
RO13.11.2024
SK13.11.2024
SM13.11.2024
RS13.02.2025
GR14.02.2025
IS13.03.2025
LU19.05.2025
Former [2025/36]BG13.11.2024
CZ13.11.2024
EE13.11.2024
HR13.11.2024
LV13.11.2024
PL13.11.2024
RO13.11.2024
SK13.11.2024
SM13.11.2024
RS13.02.2025
GR14.02.2025
IS13.03.2025
Former [2025/35]BG13.11.2024
EE13.11.2024
HR13.11.2024
LV13.11.2024
PL13.11.2024
RO13.11.2024
SM13.11.2024
RS13.02.2025
GR14.02.2025
IS13.03.2025
Former [2025/32]BG13.11.2024
HR13.11.2024
LV13.11.2024
PL13.11.2024
SM13.11.2024
RS13.02.2025
GR14.02.2025
IS13.03.2025
Former [2025/23]BG13.11.2024
HR13.11.2024
LV13.11.2024
PL13.11.2024
RS13.02.2025
GR14.02.2025
IS13.03.2025
Former [2025/22]BG13.11.2024
HR13.11.2024
LV13.11.2024
GR14.02.2025
IS13.03.2025
Former [2025/21]BG13.11.2024
HR13.11.2024
IS13.03.2025
Documents cited:Search[Y] WO2013053836  (QUANTUM PHARMACEUTICALS SA et al.) [Y] 1-4,11,14,15 * page 9, lines 19-20; claims 1-13,21 *
 [XPI]   CHARLIE G. BUFFIE ET AL: "Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile", NATURE, vol. 517, no. 7533, 22 October 2014 (2014-10-22), pages 205 - 208, XP055363406, ISSN: 0028-0836, DOI: 10.1038/nature13828 [XP] 1-4,14,15 * the whole document * [I] 11

DOI:   http://dx.doi.org/10.1038/nature13828
 [Y]   C. UBEDA ET AL: "Intestinal Microbiota Containing Barnesiella Species Cures Vancomycin-Resistant Enterococcus faecium Colonization", INFECTION AND IMMUNITY, vol. 81, no. 3, 1 March 2013 (2013-03-01), pages 965 - 973, XP055386852, ISSN: 0019-9567, DOI: 10.1128/IAI.01197-12 [Y] 1-4,11,14,15 * the whole document *

DOI:   http://dx.doi.org/10.1128/IAI.01197-12
 [Y]   ROBERT A. BRITTON ET AL: "Role of the Intestinal Microbiota in Resistance to Colonization by Clostridium difficile", GASTROENTEROLOGY, vol. 146, no. 6, 1 May 2014 (2014-05-01), US, pages 1547 - 1553, XP055436453, ISSN: 0016-5085, DOI: 10.1053/j.gastro.2014.01.059 [Y] 1-4,11,14,15 * the whole document *

DOI:   http://dx.doi.org/10.1053/j.gastro.2014.01.059
International search[XY] WO2013080561  (UNIV TOKYO et al.) [X] 7 * , paragraphs [0050], [0066] *[Y] 8
 [XY] US2011280847  (SORG JOSEPH et al.) [X] 14, 15 * , paragraphs [0040]-[0042], [0044], [0050], [0071], [0072], [0124], [0125], [0165]-[0167] *[Y] 9/1, 9/4-9/6, 10/9/1, 10/9/4-10/9/6, 11/9/1, 11/9/4-11/9/6, 27, 34, 43/1, 43/4-43/6, 44/1, 44/4-44/6, 45/1, 45/4-45/6, 46/1, 46/4-46/6, 47/1, 47/4-47/6, 48/1, 48/4-48/6
 [Y] US7326551  (MAUPIN-FURLOW JULIE A et al.) [Y] 5, 9/1, 9/4-9/6, 10/9/1, 10/9/4-10/9/6, 11/9/1, 11/9/4-11/9/6, 43/1, 43/4-43/6, 44/1, 44/4-44/6, 45/1, 45/4-45/6, 46/1, 46/4-46/6, 47/1, 47/4-47/6, 48/1, 48/4-48/6 * , column 5, lines 10-17 *
 [Y] WO2013171515  (GENOME RES LTD et al.) [Y] 8 * , abstract, page 9 *
 [Y] WO2012142605  (SAMARITAN HEALTH SERVICES et al.) [Y] 8 * , abstract, pages 3, 4 *
 [XY]   RIDLON, JM., ENZYMOLOGY AND MOLECULAR BIOLOGY OF BILE ACID 7-ALPHA- AND 7-BETA- DEHYDROXYLATION BY THE INTESTINAL BACTERIA CLOSTRIDIUM SCINDENS AND CLOSTRIDIUM HYLEMONAE. VCU THESES AND DISSERTATIONS, 2008, pages 2, 6, 26, 74, 75, 79, 98, XP055360846 [X] 1, 2, 4, 6 * ; figure 7. *[Y] 9/1, 9/4-9/6, 10/9/1, 10/9/4-10/9/6, 11/9/1, 11/9/4-11/9/6, 28, 43/1, 43/4-43/6, 44/1, 44/4-44/6, 45/1, 45/4-45/6, 46/1, 46/4-46/6, 47/1, 47/4-47/6, 48/1, 48/4-48/6
 [Y]   GIEL, JL ET AL.: "Metabolism Of Bile Salts In Mice Influences Spore Germination in Clostridium difficile.", PLOS ONE, vol. 5, no. 1, pages 2. 4. 6, XP055056664 [Y] 28, 33 * figures 4. 5A. *

DOI:   http://dx.doi.org/10.1371/journal.pone.0008740
 [Y]   MANGES, AR ET AL.: "Comparative Metagenomic Study Of Alterations To The Intestinal Microbiota And Risk Of Nosocomial Clostridum difficil-Associated Disease.", JOURNAL OF INFECTIOUS DISEASES, vol. 202, 2010, pages 2, 3, 5, XP055238579 [Y] 27, 34 * DOI: 0.1086/657319. *

DOI:   http://dx.doi.org/10.1086/657319
 [Y]   KRISHNA, SG ET AL.: "Risk Factors, Preemptive Therapy, And Antiperistaltic Agents For Clostridium difficile Infection In Cancer Patients.", TRANSPL INFECT DIS., vol. 15, 22 January 2013 (2013-01-22), pages 495, XP055238581 [Y] 27, 34 * . DOI: 10.1111/tid.12112. *

DOI:   http://dx.doi.org/10.1111/tid.12112
 [Y]   OTT,.SJ ET AL.: "Quantification of Intestinal Bacterial Populations by Real-Time PCR with a Universal Primer Set and Minor Groove Binder Probes: a Global Approach to the Enteric Flora.", JOURNAL OF CLINICAL MICROBIOLOGY, June 2004 (2004-06-01), XP002428203 [Y] 33 * ; abstract, figure 4, DOI: 10.1128/JCM.42.6.2566-2572.2004 *

DOI:   http://dx.doi.org/10.1128/JCM.42.6.2566-2572.2004
 [Y]   KANG, D ET AL.: "Clostridium scindens baiCD and baiH genes encode stereospecific 7alpha/7beta-hydroxy-3-oxo-DELTA4-cholenoic acid oxidoreductases.", BIOCHIM BIOPHYS ACTA, vol. 1781, 2008, XP022459144 [Y] 2 * ; abstract *

DOI:   http://dx.doi.org/10.1016/j.bbalip.2007.10.008
 [Y]   WELLS, JE ET AL.: "Development and application of a polymerase chain reaction assay for the detection and enumeration of bile acid 7a-dehydroxylating bacteria in human feces.", CLINICA CHIMICA ACTA., vol. 331, 2003, XP055360854 [Y] 2 * ; abstract, doi:10.1016/S0009-8981(03)00115-3 *

DOI:   http://dx.doi.org/10.1016/S0009-8981(03)00115-3
by applicantWO9408598
   TURNBAUGH, P. J.HAMADY, M.YATSUNENKO, T.CANTAREL, B. L. ET AL.: "A core gut microbiome in obese and lean twins", NATURE, vol. 457, 2009, pages 480 - 484, XP055006664, DOI: 10.1038/nature07540 [Y] 8

DOI:   http://dx.doi.org/10.1038/nature07540
   KOETH, R. A.WANG, Z.LEVISON, B. S.BUFFA, J. A. ET AL.: "Intestinal microbiota metabolism of 1-carnitine, a nutrient in red meat, promotes atherosclerosis", NAT MED, 2013 [Y] 9/1, 9/4-9/6, 10/9/1, 10/9/4-10/9/6, 11/9/1, 11/9/4-11/9/6, 27, 34, 43/1, 43/4-43/6, 44/1, 44/4-44/6, 45/1, 45/4-45/6, 46/1, 46/4-46/6, 47/1, 47/4-47/6, 48/1, 48/4-48/6
   RAKOFF-NAHOUM, S.PAGLINO, J.ESLAMI-VARZANEH, F.EDBERG, S.MEDZHITOV, R.: "Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis", CELL, vol. 118, 2004, pages 229 - 241, XP008166084, DOI: 10.1016/j.cell.2004.07.002

DOI:   http://dx.doi.org/10.1016/j.cell.2004.07.002
   IVANOV, I. I.ATARASHI, K.MANEL, N.BRODIE, E. L. ET AL.: "Induction of intestinal Thl7 cells by segmented filamentous bacteria", CELL, vol. 139, 2009, pages 485 - 498, XP055005112, DOI: 10.1016/j.cell.2009.09.033 [Y] 28, 33 * figures 4. 5A. *

DOI:   http://dx.doi.org/10.1016/j.cell.2009.09.033
   CHUNG, H.PAMP, S. J.HILL, J. A.SURANA, N. K. ET AL.: "Gut immune maturation depends on colonization with a host-specific microbiota", CELL, vol. 149, 2012, pages 1578 - 1593, XP028497257, DOI: 10.1016/j.cell.2012.04.037

DOI:   http://dx.doi.org/10.1016/j.cell.2012.04.037
   DIEHL, G. E.LONGMAN, R. S.ZHANG, J. X.BREART, B. ET AL.: "Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells", NATURE, vol. 494, 2013, pages 116 - 120, XP037227940, DOI: 10.1038/nature11809

DOI:   http://dx.doi.org/10.1038/nature11809
   DUAN, J.CHUNG, H.TROY, E.KASPER, D. L.: "Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells", CELL HOST MICROBE, vol. 7, 2010, pages 140 - 150 [Y] 27, 34 * DOI: 0.1086/657319. *
   FARACHE, J.KOREN, I.MILO, I.GUREVICH, I. ET AL.: "Luminal Bacteria Recruit CD103(+) Dendritic Cells into the Intestinal Epithelium to Sample Bacterial Antigens for Presentation", IMMUNITY, vol. 38, 2013, pages 581 - 595 [Y] 27, 34 * . DOI: 10.1111/tid.12112. *
   OLSZAK, T.AN, D.ZEISSIG, S.VERA, M. P. ET AL.: "Microbial exposure during early life has persistent effects on natural killer T cell function", SCIENCE, vol. 336, 2012, pages 1553 - 1556 [Y] 33 * ; abstract, figure 4, DOI: 10.1128/JCM.42.6.2566-2572.2004 *
   WINGENDER, G.STEPNIAK, D.KREBS, P.LIN, L. ET AL.: "Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice", GASTROENTEROLOGY, vol. 143, 2012, pages 418 - 428, XP028449325, DOI: 10.1053/j.gastro.2012.04.017 [Y] 2 * ; abstract *

DOI:   http://dx.doi.org/10.1053/j.gastro.2012.04.017
   HILL, D. A.SIRACUSA, M. C.ABT, M. C.KIM, B. S. ET AL.: "Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation", NAT MED, vol. 18, 2012, pages 538 - 546 [Y] 2 * ; abstract, doi:10.1016/S0009-8981(03)00115-3 *
   LATHROP, S. K.BLOOM, S. M.RAO, S. M.NUTSCH, K. ET AL.: "Peripheral education of the immune system by colonic commensal microbiota", NATURE, vol. 478, 2011, pages 250 - 254
   MACPHERSON, A. J.UHR, T.: "Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria", SCIENCE, vol. 303, 2004, pages 1662 - 1665, XP055046628, DOI: 10.1126/science.1091334

DOI:   http://dx.doi.org/10.1126/science.1091334
   BASLER, M.HO, B. T.MEKALANOS, J. J.: "Tit-for-tat: type VI secretion system counterattack during bacterial cell-cell interactions", CELL, vol. 152, 2013, pages 884 - 894, XP028979909, DOI: 10.1016/j.cell.2013.01.042

DOI:   http://dx.doi.org/10.1016/j.cell.2013.01.042
   BASLER, M.PILHOFER, M.HENDERSON, G. P.JENSEN, G. J.MEKALANOS, J. J.: "Type VI secretion requires a dynamic contractile phage tail-like structure", NATURE, vol. 483, 2012, pages 182 - 186
   REA, PROC NATL ACAD SCI USA, vol. 108, no. 1, 2011, pages 4639 - 4644
   REA, PROC NATL ACAD SCI USA, vol. 107, 2010, pages 9352 - 9357
   ABT, M. C.OSBORNE, L. C.MONTICELLI, L. A.DOERING, T. A. ET AL.: "Commensal bacteria calibrate the activation threshold of innate antiviral immunity", IMMUNITY, vol. 37, 2012, pages 158 - 170, XP055808532, DOI: 10.1016/j.immuni.2012.04.011

DOI:   http://dx.doi.org/10.1016/j.immuni.2012.04.011
   "GenBank", Database accession no. ABFY 02000000
   MCAULIFFE ET AL., APPL ENVIRON MICROBIOL., vol. 71, no. 8, August 2005 (2005-08-01), pages 4925 - 9
   BEGLEY ET AL., APPL ENVIRON MICROBIOL., vol. 72, no. 3, March 2006 (2006-03-01), pages 1729 - 38
   ATTA, WORLD J GASTROENTEROL., vol. 16, no. 32, 28 August 2010 (2010-08-28), pages 4019 - 4030
   KRONKREPPEL, CURR GENE THER, vol. 12, no. 5, 2012, pages 362 - 73
   YI ET AL., CURR GENE THER, vol. 11, no. 3, 2011, pages 218 - 28
   GOLDSPIEL ET AL., CLINICAL PHARMACY, vol. 12, 1993, pages 488 - 505
   WUWU, BIOTHERAPY, vol. 3, 1991, pages 87 - 95
   TOLSTOSHEV, ANN. REV. PHARMACOL. TOXICOL., vol. 32, 1993, pages 573 - 596
   MULLIGAN, SCIENCE, vol. 260, 1993, pages 926 - 932
   MORGANANDERSON, ANN. REV. BIOCHEM., vol. 62, 1993, pages 191 - 217
   MAY, TIBTECH, vol. 11, no. 5, 1993, pages 155 - 215
   COHEN ET AL., METH. ENZYMOL., vol. 217, 1993, pages 618 - 644
   KRIEGLER: "A Laboratory Manual", 1990, STOCKTON PRESS, article "Gene Transfer and Expression"
   CLINE, PHARMAC. THER., vol. 29, 1985, pages 69 - 92m
   PORADAPORADA, J. GENET SYNDR GENE THER., vol. 25, 2012, pages 1
   STEMPLEANDERSON, CELL, vol. 71, 1992, pages 973 - 985
   RHEINWALD, METH. CELL BIO., vol. 21A, 1980, pages 229
   PITTELKOWSCOTT, MAYO CLINIC PROC., vol. 61, 1986, pages 771
   MORRIS ET AL.: "Clostridium scindens sp. nov., a Human Intestinal Bacterium with Desmolytic Activity on Corticoids", INT J SYST BACTERIOL, vol. 35, October 1985 (1985-10-01), pages 478 - 481
   KRAFFT ET AL.: "Purification and characterization of a novel form of 20 alpha-hydroxysteroid dehydrogenase from Clostridium scindens", J. BACTERIOL., vol. 171, June 1989 (1989-06-01), pages 2925 - 2932
   BUFFIEPAMER: "Microbiota-mediated colonization resistance against intestinal pathogens", NATURE REVIEWS IMMUNOLOGY, vol. 13, 2013, pages 790 - 801
   RIDLON JMHYLEMON PB: "Identification and characterization of two bile-acid coenzyme A transferases from Clostridium scindens, a bile acid 7a-dehydroxylating intestinal bacterium", J. LIPID RES., vol. 53, 2012, pages 66 - 76
   RIDLON, J. M.KANG, D. J.HYLEMON, P. B.: "Bile salt biotransformations by human intestinal bacteria", J LIPID RES, vol. 47, 2006, pages 241 - 259
   "Remington's Pharmaceutical Sciences", 1980, MACK
   ZAR FABAKKANAGARI SR ET AL.: "A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity", CLIN. INFECT. DIS., vol. 45, 2007, pages 302 - 307, XP055192004, DOI: 10.1086/519265

DOI:   http://dx.doi.org/10.1086/519265
   RIDLON JM ET AL.: "Clostridium scindens: a human gut microbe with a high potential to convert glucocorticoids into androgens", J. LIPID RES., vol. 54, 2013, pages 2437 - 2449
   RUPNIK, M.WILCOX, M. H.GERDING, D. N.: "Clostridium difficile infection: new developments in epidemiology and pathogenesis", NAT REV MICROBIOL, vol. 7, 2009, pages 526 - 536, XP009169073, DOI: 10.1038/nrmicro2164

DOI:   http://dx.doi.org/10.1038/nrmicro2164
   SURAWICZ, C. M.ALEXANDER, J.: "Treatment of refractory and recurrent Clostridium difficile infection", NAT REV GASTROENTEROL HEPATOL, vol. 8, 2011, pages 330 - 339
   HAND, T. W.DOS SANTOS, L. M.BOULADOUX, N.MOLLOY, M. J. ET AL.: "Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses", SCIENCE, vol. 337, 2012, pages 1553 - 1556
   REA, M. C.DOBSON, A.O'SULLIVAN, O.CRISPIE, F. ET AL.: "Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon", PROC NATL ACAD SCI U S A, vol. 108, no. 1, 2011, pages 4639 - 4644
   REA, M. C.SIT, C. S.CLAYTON, E.O'CONNOR, P. M. ET AL.: "Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile", PROC NATL ACAD SCI U S A, vol. 107, 2010, pages 9352 - 9357
   HUSE, S. M.DETHLEFSEN, L.HUBER, J. A.MARK WELCH, D. ET AL.: "Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing", PLOS GENET, vol. 4, 2008, pages e1000255
   DETHLEFSEN, L.RELMAN, D. A.: "Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation", PROC NATL ACAD SCI U S A, vol. 108, no. 1, 2011, pages 4554 - 4561
   BUFFIE, C. G.JARCHUM, I.EQUINDA, M.LIPUMA, L. ET AL.: "Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis", INFECT IMMUN, vol. 80, 2012, pages 62 - 73
   BRANDL, K.PLITAS, G.MIHU, C. N.UBEDA, C. ET AL.: "Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits", NATURE, vol. 455, 2008, pages 804 - 807
   UBEDA, C.TAUR, Y.JENQ, R. R.EQUINDA, M. J. ET AL.: "Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans", J CLIN INVEST, vol. 120, 2010, pages 4332 - 4341, XP055386855, DOI: 10.1172/JCI43918

DOI:   http://dx.doi.org/10.1172/JCI43918
   FERREIRA, R. B.GILL, N.WILLING, B. P.ANTUNES, L. C. ET AL.: "The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization", PLOS ONE, vol. 6, 2011, pages e20338
   KYNE, L.HAMEL, M. B.POLAVARAM, R.KELLY, C. P.: "Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile", CLIN INFECT DIS, vol. 34, 2002, pages 346 - 353
   ZILBERBERG, M. D.SHORR, A. F.KOLLEF, M. H.: "Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005", EMERG INFECT DIS, vol. 14, 2008, pages 929 - 931
   MARSH, J. W.ARORA, R.SCHLACKMAN, J. L.SHUTT, K. A. ET AL.: "Association of relapse of Clostridium difficile disease with BI/NAP1/027", J CLIN MICROBIOL, vol. 50, 2012, pages 4078 - 4082
   BAKKEN, J. S.BORODY, T.BRANDT, L. J.BRILL, J. V. ET AL.: "Treating Clostridium difficile infection with fecal microbiota transplantation", CLIN GASTROENTEROL HEPATOL, vol. 9, 2011, pages 1044 - 1049, XP009155259, DOI: 10.1016/j.cgh.2011.08.014

DOI:   http://dx.doi.org/10.1016/j.cgh.2011.08.014
   VAN NOOD, E.VRIEZE, A.NIEUWDORP, M.FUENTES, S. ET AL.: "Duodenal infusion of donor feces for recurrent Clostridium difficile", N ENGL J MED, vol. 368, 2013, pages 407 - 415, XP055095085, DOI: 10.1056/NEJMoa1205037

DOI:   http://dx.doi.org/10.1056/NEJMoa1205037
   PAMER, E. G.: "Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns", MUCOSAL IMMUNOL, vol. 7, 2014, pages 210 - 214, XP055719149, DOI: 10.1038/mi.2013.117

DOI:   http://dx.doi.org/10.1038/mi.2013.117
   REEVES, A. E.THERIOT, C. M.BERGIN, I. L.HUFFNAGLE, G. B. ET AL.: "The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection", GUT MICROBES, vol. 2, 2011, pages 145 - 158
   LAWLEY, T. D.CLARE, S.WALKER, A. W.STARES, M. D. ET AL.: "Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice", PLOS PATHOG, vol. 8, 2012, pages e1002995, XP055077330, DOI: 10.1371/journal.ppat.1002995

DOI:   http://dx.doi.org/10.1371/journal.ppat.1002995
   PETROF, E. O.GLOOR, G. B.VANNER, S. J.WEESE, S. J. ET AL.: "Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut", MICROBIOME, vol. 1, 2013, pages 3, XP021138289, DOI: 10.1186/2049-2618-1-3

DOI:   http://dx.doi.org/10.1186/2049-2618-1-3
   HAMILTON, M. J.WEINGARDEN, A. R.UNNO, T.KHORUTS, A.SADOWSKY, M. J.: "High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria", GUT MICROBES, vol. 4, 2013, pages 125 - 135
   CHANG, J. Y.ANTONOPOULOS, D. A.KALRA, A.TONELLI, A. ET AL.: "Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea", J INFECT DIS, vol. 197, 2008, pages 435 - 438
   LOZUPONE, C.KNIGHT, R.: "UniFrac: a new phylogenetic method for comparing microbial communities", APPL ENVIRON MICROBIOL, vol. 71, 2005, pages 8228 - 8235
   TAUR, Y.XAVIER, J. B.LIPUMA, L.UBEDA, C. ET AL.: "Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation", CLIN INFECT DIS, vol. 55, 2012, pages 905 - 914, XP055297806, DOI: 10.1093/cid/cis580

DOI:   http://dx.doi.org/10.1093/cid/cis580
   KINNEBREW, M. A.LEE, Y. J.JENQ, R. R.LIPUMA, L. ET AL.: "Early Clostridium difficile Infection during Allogeneic Hematopoietic Stem Cell Transplantation", PLOS ONE, vol. 9, 2014, pages e90158
   STEIN, R. R.BUCCI, V.TOUSSAINT, N. C.BUFFIE, C. G. ET AL.: "Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiota", PLOS COMPUTBIOL, vol. 9, 2013, pages e1003388
   CHEN, X.KATCHAR, K.GOLDSMITH, J. D.NANTHAKUMAR, N. ET AL.: "A mouse model of Clostridium difficile-associated disease", GASTROENTEROLOGY, vol. 135, 2008, pages 1984 - 1992, XP026147662, DOI: 10.1053/j.gastro.2008.09.002

DOI:   http://dx.doi.org/10.1053/j.gastro.2008.09.002
   SORG, J. A.SONENSHEIN, A. L.: "Bile salts and glycine as cogerminants for Clostridium difficile spores", J BACTERIOL, vol. 190, 2008, pages 2505 - 2512, XP002636062, DOI: 10.1128/JB.01765-07

DOI:   http://dx.doi.org/10.1128/JB.01765-07
   DE AGUIAR VALLIM, T. Q.TARLING, E. J.EDWARDS, P. A.: "Pleiotropic roles of bile acids in metabolism", CELL METAB, vol. 17, 2013, pages 657 - 669
   KANG, D. J.RIDLON, J. M.MOORE, D. R.BARNES, S.HYLEMON, P. B.: "Clostridium scindens baiCD and baiH genes encode stereo-specific 7alpha/7beta-hydroxy-3-oxo-delta4-cholenoic acid oxidoreductases", BIOCHIM BIOPHYS ACTA, vol. 1781, 2008, pages 16 - 25, XP022459144, DOI: 10.1016/j.bbalip.2007.10.008

DOI:   http://dx.doi.org/10.1016/j.bbalip.2007.10.008
   LANGILLE, M. G.ZANEVELD, J.CAPORASO, J. G.MCDONALD, D. ET AL.: "Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences", NAT BIOTECHNOL, vol. 31, 2013, pages 814 - 821, XP055328402, DOI: 10.1038/nbt.2676

DOI:   http://dx.doi.org/10.1038/nbt.2676
   WELLS, J. E.WILLIAMS, K. B.WHITEHEAD, T. R.HEUMAN, D. M.HYLEMON, P. B.: "Development and application of a polymerase chain reaction assay for the detection and enumeration of bile acid 7a-dehydroxylating bacteria in human feces", CLINICA CHIMICA ACTA, vol. 331, 2003, pages 127 - 134, XP055360854, DOI: 10.1016/S0009-8981(03)00115-3

DOI:   http://dx.doi.org/10.1016/S0009-8981(03)00115-3
   BARRASA, J. I.OLMO, N.LIZARBE, M. A.TURNAY, J.: "Bile acids in the colon, from healthy to cytotoxic molecules", TOXICOL IN VITRO, vol. 27, 2013, pages 964 - 977
   KITAHARA, M.TAKAMINE, F.IMAMURA, T.BENNO, Y.: "Assignment of Eubacterium sp. VPI 12708 and related strains with high bile acid 7alpha-dehydroxylating activity to Clostridium scindens and proposal of Clostridium hylemonae sp. nov., isolated from human faeces", INT J SYST EVOL MICROBIOL, vol. 50, 2000, pages 971 - 978
   WELLS, . E.HYLEMON, . B.: "Identification and Characterization of a Bile Acid 7alpha - Dehydroxylation Operon in Clostridium sp. Strain TO-931, a Highly Active 7alpha - Dehydroxylating Strain Isolated from Human Feces", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 66, 2000, pages 1107 - 1113
   COLLINS, M. D.LAWSON, P. A.WILLEMS, A.CORDOBA, J. J. ET AL.: "The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations", INT J SYST BACTERIOL, vol. 44, 1994, pages 812 - 826, XP055107539, DOI: 10.1099/00207713-44-4-812

DOI:   http://dx.doi.org/10.1099/00207713-44-4-812
   LIU, C.FINEGOLD, S. M.SONG, Y.LAWSON, P. A.: "Reclassification of Clostridium coccoides, Ruminococcus hansenii, Ruminococcus hydrogenotrophicus, Ruminococcus luti, Ruminococcus productus and Ruminococcus schinkii as Blautia coccoides gen. nov. , comb. nov. , Blautia hansenii comb. nov. , Blautia hydrogenotrophica comb. nov. , Blautia luti comb.", INT J SYST EVOL MICROBIOL, vol. 58, 2008, pages 1896 - 1902, XP055005236, DOI: 10.1099/ijs.0.65208-0

DOI:   http://dx.doi.org/10.1099/ijs.0.65208-0
   CARLIER, J. P.BEDORA-FAURE, M.K'OUAS, G.ALAUZET, C.MORY, F. ET AL.: "Proposal to unify Clostridium orbiscindens Winter et al. 1991 and Eubacterium plautii (Seguin 1928) Hofstad and Aasjord 1982, with description of Flavonifractor plautii gen. nov., comb. nov., and reassignment of Bacteroides capillosus to Pseudoflavonifractor capillosus gen. nov., comb. nov.", INT J SYST EVOL MICROBIOL, vol. 60, 2010, pages 585 - 590, XP055709216, DOI: 10.1099/ijs.0.016725-0

DOI:   http://dx.doi.org/10.1099/ijs.0.016725-0
   YUTIN, N.GALPERIN, M. Y.: "A genomic update on clostridial phylogeny: Gram-negative spore formers and other misplaced clostridia", ENVIRON MICROBIOL, vol. 15, 2013, pages 2631 - 2641
   THERIOT, C. M.KOENIGSKNECHT, M. J.CARLSON, P. E.HATTON, G. E. ET AL.: "Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection", NATURE COMMUNICATIONS, vol. 5, 2014, XP055371377, DOI: 10.1038/ncomms4114

DOI:   http://dx.doi.org/10.1038/ncomms4114
   WEINGARDEN, A. R.CHEN, C.BOBR, A.YAO, D. ET AL.: "Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection", AM J PHYSIOL GASTROINTEST LIVER PHYSIOL, vol. 306, 2014, pages G310 - G319, XP055425865, DOI: 10.1152/ajpgi.00282.2013

DOI:   http://dx.doi.org/10.1152/ajpgi.00282.2013
   LOUIE, T. J.PEPPE, J.WATT, C. K.JOHNSON, D. ET AL.: "Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea", CLIN INFECT DIS, vol. 43, 2006, pages 411 - 420, XP008152137, DOI: 10.1086/506349

DOI:   http://dx.doi.org/10.1086/506349
   GIEL, J. L.SORG, J. A.SONENSHEIN, A. L.ZHU, J.: "Metabolism of bile salts in mice influences spore germination in Clostridium difficile", PLOS ONE, vol. 5, 2010, pages e8740, XP055056664, DOI: 10.1371/journal.pone.0008740

DOI:   http://dx.doi.org/10.1371/journal.pone.0008740
   SORG, J. A.SONENSHEIN, A. L.: "Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination", J BACTERIOL, vol. 191, 2009, pages 1115 - 1117, XP055027727, DOI: 10.1128/JB.01260-08

DOI:   http://dx.doi.org/10.1128/JB.01260-08
   OUT, C.GROEN, A. K.BRUFAU, G.: "Bile acid sequestrants: more than simple resins", CURR OPIN LIPIDOL, vol. 23, 2012, pages 43 - 55
   BERNSTEIN, H.BERNSTEIN, C.PAYNE, C. M.DVORAKOVA, K.GAREWAL, H.: "Bile acids as carcinogens in human gastrointestinal cancers", MUTAT RES, vol. 589, 2005, pages 47 - 65, XP086368520, DOI: 10.1016/j.mrrev.2004.08.001

DOI:   http://dx.doi.org/10.1016/j.mrrev.2004.08.001
   EDGAR, R. C.HAAS, B. J.CLEMENTE, J. C.QUINCE, C.KNIGHT, R.: "UCHIME improves sensitivity and speed of chimera detection", BIOINFORMATICS, vol. 27, 2011, pages 2194 - 2200, XP055534113, DOI: 10.1093/bioinformatics/btr381

DOI:   http://dx.doi.org/10.1093/bioinformatics/btr381
   SCHLOSS, P. D.WESTCOTT, S. L.RYABIN, T.HALL, J. R. ET AL.: "Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities", APPL ENVIRON MICROBIOL, vol. 75, 2009, pages 7537 - 7541, XP055154024, DOI: 10.1128/AEM.01541-09

DOI:   http://dx.doi.org/10.1128/AEM.01541-09
   "Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome", NATURE, vol. 486, 2012, pages 207 - 214
   CAPORASO, J. G.LAUBER, C. L.WALTERS, W. A.BERG-LYONS, D. ET AL.: "Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms", ISME J, vol. 6, 2012, pages 1621 - 1624, XP055341618, DOI: 10.1038/ismej.2012.8

DOI:   http://dx.doi.org/10.1038/ismej.2012.8
   UBEDA, C.BUCCI, V.CABALLERO, S.DJUKOVIC, A. ET AL.: "Intestinal microbiota containing Barnesiella cures vancomycin-resistant Enterococcus faecium colonization", INFECT IMMUN, vol. 81, 2013, pages 965 - 973, XP055386852, DOI: 10.1128/IAI.01197-12

DOI:   http://dx.doi.org/10.1128/IAI.01197-12
   SHENEMAN, L.EVANS, J.FOSTER, J. A.: "Clearcut: a fast implementation of relaxed neighbor joining", BIOINFORMATICS, vol. 22, 2006, pages 2823 - 2824
   JG CAPORASOJ KUCZYNSKIJ STOMBAUGHK BITTINGERFD BUSHMANEK COSTELLON FIERERAG PENAJK GOODRICHJI GORDON: "QIIME allows analysis of high-throughput community sequencing data", NAT METHODS, vol. 7, no. 5, May 2010 (2010-05-01), pages 335 - 6
   HALL, B. G.: "Building phylogenetic trees from molecular data with MEGA", MOL BIOL EVOL, vol. 30, 2013, pages 1229 - 1235
   ZHAO, Y.TANG, H.YE, Y: "RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data", BIOINFORMATICS, vol. 28, 2012, pages 125 - 126
   COHEN, J., ROUTLEDGE, vol. Statistical power analysis for the behavioral scie, 1988
   STEIN, R. R.BUCCI, V.TOUSSAINT, N. C.BUFFIE, C. G. ET AL.: "Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiota", PLOS COMPUT BIOL, vol. 9, 2013, pages e1003388
   BARTLETT JGCHANG TWGURWITH M ET AL.: "Antibiotic-associated psudomembranous colitis due to toxin-producing clostridia", N. ENGL. J. MED., vol. 298, 1978, pages 531 - 534
   CHEN XLAMONT JT: "Overview of Clostridium difficile infection: implications for China", GASTROENTEROLOGY REPORT, vol. 1, 2013, pages 153 - 158
   RIDLON JM ET AL.: "Bile salt biotransformations by Human Intestinal bacteria", J. LIPID RES., vol. 47, 2006, pages 241 - 259
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.